Citadel Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.4M Buy
1,304,700
+799,600
+158% +$15.5M ﹤0.01% 1921
2025
Q4
$10.9M Sell
505,100
-105,500
-17% -$2.22M ﹤0.01% 3149
2025
Q3
$11.8M Buy
610,600
+280,300
+85% +$5M ﹤0.01% 3025
2025
Q2
$5.65M Buy
330,300
+217,000
+192% +$9.26M ﹤0.01% 3895
2025
Q1
$7.23M Sell
113,300
-14,500
-11% -$1.53M ﹤0.01% 3318
2024
Q4
$15.5M Sell
127,800
-180,200
-59% -$22.1M ﹤0.01% 2439
2024
Q3
$38.5M Sell
308,000
-78,100
-20% -$10.8M 0.01% 1458
2024
Q2
$61M Buy
386,100
+55,000
+17% +$7.07M 0.01% 996
2024
Q1
$42.9M Sell
331,100
-65,700
-17% -$8.05M 0.01% 1351
2023
Q4
$38.3M Sell
396,800
-15,300
-4% -$1.47M 0.01% 1397
2023
Q3
$50M Buy
412,100
+136,000
+49% +$15.4M 0.01% 1076
2023
Q2
$31.6M Sell
276,100
-206,900
-43% -$26.7M 0.01% 1427
2023
Q1
$66.6M Buy
483,000
+142,200
+42% +$18.4M 0.01% 869
2022
Q4
$44.2M Buy
340,800
+6,000
+2% +$695K 0.01% 1224
2022
Q3
$37M Buy
334,800
+196,100
+141% +$19.8M 0.01% 1301
2022
Q2
$10.4M Sell
138,700
-10,400
-7% -$765K ﹤0.01% 2640
2022
Q1
$11.6M Sell
149,100
-48,000
-24% -$3.68M ﹤0.01% 2726
2021
Q4
$17.7M Buy
197,100
+10,500
+6% +$898K ﹤0.01% 2170
2021
Q3
$17.3M Buy
186,600
+45,500
+32% +$3.5M ﹤0.01% 2219
2021
Q2
$11M Sell
141,100
-121,900
-46% -$9.24M ﹤0.01% 2945
2021
Q1
$19.6M Sell
263,000
-134,800
-34% -$12.4M ﹤0.01% 1982
2020
Q4
$67.8M Buy
397,800
+177,900
+81% +$26.4M 0.02% 762
2020
Q3
$30.9M Buy
219,900
+2,600
+1% +$395K 0.01% 1193
2020
Q2
$34.8M Sell
217,300
-103,100
-32% -$14M 0.01% 1042
2020
Q1
$31.3M Sell
320,400
-316,500
-50% -$36.2M 0.01% 895
2019
Q4
$82.2M Buy
636,900
+226,100
+55% +$22.8M 0.04% 500
2019
Q3
$30.9M Buy
410,800
+36,500
+10% +$4.31M 0.01% 1099
2019
Q2
$56.9M Buy
374,300
+55,300
+17% +$6.72M 0.03% 660
2019
Q1
$38M Sell
319,000
-28,700
-8% -$3.69M 0.02% 853
2018
Q4
$37.9M Buy
347,700
+58,400
+20% +$7.3M 0.02% 772
2018
Q3
$46.7M Buy
289,300
+53,200
+23% +$7.27M 0.02% 800
2018
Q2
$31.2M Buy
236,100
+70,400
+42% +$6.64M 0.02% 965
2018
Q1
$12.3M Buy
165,700
+30,600
+23% +$2.04M 0.01% 1533
2017
Q4
$7.52M Hold
135,100
﹤0.01% 2013
2017
Q3
$6.13M Buy
135,100
+55,700
+70% +$2.23M ﹤0.01% 2090
2017
Q2
$2.68M Sell
79,400
-24,000
-23% -$781K ﹤0.01% 2790
2017
Q1
$3.06M Sell
103,400
-66,600
-39% -$2.06M ﹤0.01% 2556
2016
Q4
$4.66M Sell
170,000
-33,000
-16% -$1.33M ﹤0.01% 2080
2016
Q3
$12.5M Sell
203,000
-172,500
-46% -$5.22M 0.01% 1186
2016
Q2
$7.16M Buy
375,500
+223,300
+147% +$4.14M 0.01% 1515
2016
Q1
$2.97M Buy
152,200
+106,800
+235% +$1.87M ﹤0.01% 2258
2015
Q4
$1.75M Sell
45,400
-8,200
-15% -$266K ﹤0.01% 2877
2015
Q3
$1.72M Buy
53,600
+7,100
+15% +$241K ﹤0.01% 3135
2015
Q2
$1.42M Buy
46,500
+12,700
+38% +$260K ﹤0.01% 3502
2015
Q1
$449K Sell
33,800
-23,700
-41% -$316K ﹤0.01% 5062
2014
Q4
$832K Sell
57,500
-9,900
-15% -$168K ﹤0.01% 4000
2014
Q3
$1.42M Buy
67,400
+39,200
+139% +$885K ﹤0.01% 3266
2014
Q2
$840K Sell
28,200
-53,300
-65% -$1.68M ﹤0.01% 3728
2014
Q1
$1.96M Buy
81,500
+3,000
+4% +$76.5K ﹤0.01% 2682
2013
Q4
$1.6M Buy
78,500
+15,800
+25% +$469K ﹤0.01% 2762
2013
Q3
$2.96M Buy
62,700
+7,600
+14% +$293K ﹤0.01% 2034
2013
Q2
$2.1M Buy
+55,100
New +$1.97M ﹤0.01% 2449

Other funds holding SRPT